Laparoscopic Sleeve Gastrectomy With and Without Omentectomy

Metabolic Effects of Laparoscopic Sleeve Gastrectomy With or Without Omentectomy: Prospective Randomized Trial

• The investigators aim to determine the clinical and metabolic effects of sleeve gastrectomy with or without omentectomy in the treatment of morbid obesity.
• The investigators hypothesize that the endocrine suppression of ghrelin (appetite hormone)and resistin (insulin antagonist) provided by sleeve gastrectomy and omentectomy (omentum or intra-abdominal fat removal) will provide clinical and metabolic benefits for morbidly obese patients.

This is a phase 3 prospective randomized trial.

Inclusion Criteria:

• Morbidly obese VETERANS ONLY (BMI>35 with comorbidities or BMI>40)
• Age > 18

Exclusion Criteria:

• Pregnancy
• Uncontrolled medical or psychiatric conditions
• Previous bariatric procedure